Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2000
12/28/2000WO2000078793A2 Antimicrobial agents
12/28/2000WO2000078344A1 Prion protein peptides and uses thereof
12/28/2000WO2000056353A3 A uro-genital condition treatment system
12/28/2000WO2000017369B1 Alzheimer's disease secretase
12/28/2000CA2377648A1 Prion protein peptides and uses thereof
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2276542A1 Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
12/27/2000EP1062949A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS
12/27/2000EP1062878A1 Mixed crystals comprising aspartame and aspartame derivative and process for producing the same
12/27/2000EP1062231A1 Process for the preparation of a tetrapeptide
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1061937A1 Improved radiation therapy methods
12/27/2000EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
12/27/2000EP0751768B1 Anti-viral and anti-cancer agent
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/26/2000US6166217 Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166086 Small molecules that increase the conversion of food to body weight gain
12/26/2000US6165717 Method of synthesizing diverse collections of oligomers
12/26/2000CA2182476C Macrocyclic difluorostatone derivatives useful as antiviral agents
12/26/2000CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077032A2 Spermine:peptide-based surfactant compounds
12/21/2000WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000WO2000076504A1 Production of agglomerates of inogatran and the compound inogatran anhydrate
12/21/2000WO2000044366A3 Therapeutic compositions containing glutathione analogs
12/21/2000CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/20/2000EP1060190A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
12/20/2000EP1059919A1 Small molecules that increase the conversion of food to body weight gain
12/20/2000EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/20/2000EP0823848A4 Tissue adhesive using synthetic cross-linking
12/20/2000EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
12/19/2000US6162828 Cysteine protease inhibitor
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000US6162783 Liquid detergents containing proteolytic enzyme and protease inhibitors
12/19/2000US6162434 Cytomodulating peptide for inhibiting lymphocyte activity
12/19/2000CA2189527C Novel elastase inhibitors
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000CA2390090A1 Peptides
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/13/2000EP1059302A1 Factor VIIa inhibitors
12/13/2000EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/13/2000EP1058689A1 Alpha-ketoamide inhibitors of 20s proteasome
12/13/2000EP1058687A1 Nucleosides
12/13/2000CN1276795A Process for purification of aspartame deriv.
12/13/2000CN1276727A Growth hormone secretagogues
12/13/2000CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv.
12/12/2000US6160176 Anticoagulant agents
12/12/2000US6159938 Serine protease inhibitors comprising α-keto heterocycles
12/12/2000CA2131186C Isosteric antiherpes peptide derivatives
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/12/2000CA2036413C Hiv protease inhibitors
12/12/2000CA2036397C Hiv protease inhibitors containing derived amino acid units
12/07/2000WO2000073437A1 Assays for caspase activity using green fluorescent proteins
12/07/2000WO2000073341A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073332A1 Annexin derivatives with endogenous chelation sites
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2377948A1 Annexin derivatives with endogenous chelation sites
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2374369A1 Assays for caspase activity using green fluorescent proteins
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/06/2000EP1057491A1 Preventives/remedies for skin aging
12/06/2000EP1056770A1 Novel disulfides and thiol compounds
12/06/2000EP1056722A1 Bisulfate salt of hiv protease inhibitor
12/06/2000EP1056704A1 Antitumor agents
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275333A Process for preparation of glyconitrogen and amphoteric nitrogen mixture
12/05/2000US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
12/05/2000US6156889 Reagent useful for cleaving a protected functional group
12/05/2000US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/05/2000US6156754 Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)
12/05/2000US6156732 A (di, tri or tetra)oligopeptide
12/05/2000US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications
12/05/2000CA2098921C Angiogenic peptides
12/05/2000CA2026655C Process for the solubilisation of peptides and process for the synthesis of peptides
11/2000
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071569A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000CA2373816A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/29/2000EP1055683A1 Novel acetamide derivative and use thereof
11/29/2000EP1054960A1 Heteroaromatic oligoamides as affinity ligands
11/29/2000EP1054892A1 Azole peptidomimetics as thrombin receptor antagonists
11/29/2000EP1054891A1 Prodrugs
11/29/2000EP0931069B1 Process for preparing amidines
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153613 2,3-diketopiperazine derivatives or their salts
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis